Last 12 months
Inside the activity.
2 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 16 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2020 Filed Sep 15, 2020 23:25 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 6,250 | $29.43 | $183,937.50 |
DisclosureSEC source: 0001209191-20-050596 · doc4.xml · nonDerivative · entry 4 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020. Read SEC document |
| September 15, 2020 Filed Sep 15, 2020 23:25 UTC |
FORD KATHLEENChief Operating Officer
|
Exercise / conversionCommon Stock | 6,250 | $19.43 | $121,437.50 |
DisclosureSEC source: 0001209191-20-050596 · doc4.xml · nonDerivative · entry 3 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:25 UTC |
FORD KATHLEENChief Operating Officer
|
Exercise / conversionOption to purchase common stock · Derivative | 6,250 | $0.00 Strike: $19.43 | $0.00 |
DisclosureSEC source: 0001209191-20-050596 · doc4.xml · derivative · entry 5 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,750 Underlying: Common Stock · 6,250 shares Expires 2029-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020. F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on August 9, 2019. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:25 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 6,250 | $29.43 | $183,937.50 |
DisclosureSEC source: 0001209191-20-050596 · doc4.xml · nonDerivative · entry 2 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:25 UTC |
FORD KATHLEENChief Operating Officer
|
Exercise / conversionCommon Stock | 6,250 | $19.43 | $121,437.50 |
DisclosureSEC source: 0001209191-20-050596 · doc4.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:23 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionOption to purchase common stock · Derivative | 2,102 | $0.00 Strike: $19.40 | $0.00 |
DisclosureSEC source: 0001209191-20-050592 · doc4.xml · derivative · entry 5 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,898 Underlying: Common Stock · 2,102 shares Expires 2028-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F3 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on August 21, 2018. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:23 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionOption to purchase common stock · Derivative | 7,898 | $0.00 Strike: $15.47 | $0.00 |
DisclosureSEC source: 0001209191-20-050592 · doc4.xml · derivative · entry 4 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 7,898 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on January 22, 2019. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:23 UTC |
GRASSO MARCCFO, CBO
|
SaleCommon Stock | 10,000 | $29.00 | $290,000.00 |
DisclosureSEC source: 0001209191-20-050592 · doc4.xml · nonDerivative · entry 3 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:23 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionCommon Stock | 2,102 | $29.00 | $60,958.00 |
DisclosureSEC source: 0001209191-20-050592 · doc4.xml · nonDerivative · entry 2 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:23 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionCommon Stock | 7,898 | $29.00 | $229,042.00 |
DisclosureSEC source: 0001209191-20-050592 · doc4.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 23:22 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 98,490 | $28.82 | $2,838,875.76 |
DisclosureSEC source: 0001209191-20-050590 · doc4.xml · nonDerivative · entry 4 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Araxes Pharma LLC Disclosed balance after: 206,736 F2 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $28.00 to $29.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 23:22 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 17,926 | $0.00 Strike: $6.15 | $0.00 |
DisclosureSEC source: 0001209191-20-050590 · doc4.xml · derivative · entry 6 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,021 Underlying: Common Stock · 17,926 shares Expires 2027-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F4 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on January 23, 2017. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 23:22 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 485 | $28.00 | $13,580.00 |
DisclosureSEC source: 0001209191-20-050590 · doc4.xml · nonDerivative · entry 3 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Araxes Pharma LLC Disclosed balance after: 305,226 F2 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 23:22 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 17,926 | $28.00 | $501,928.00 |
DisclosureSEC source: 0001209191-20-050590 · doc4.xml · nonDerivative · entry 2 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 23:22 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,926 | $6.15 | $110,244.90 |
DisclosureSEC source: 0001209191-20-050590 · doc4.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 22:05 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 37,030 | $0.00 Strike: $6.15 | $0.00 |
DisclosureSEC source: 0001209191-20-050028 · doc4.xml · derivative · entry 6 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,947 Underlying: Common Stock · 37,030 shares Expires 2027-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F3 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on January 23, 2017. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 22:05 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 37,030 | $28.00 | $1,036,840.00 |
DisclosureSEC source: 0001209191-20-050028 · doc4.xml · nonDerivative · entry 4 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F2 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 22:05 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 37,030 | $6.15 | $227,734.50 |
DisclosureSEC source: 0001209191-20-050028 · doc4.xml · nonDerivative · entry 3 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 22:05 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 1,025 | $28.00 | $28,700.00 |
DisclosureSEC source: 0001209191-20-050028 · doc4.xml · nonDerivative · entry 2 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Araxes Pharma LLC Disclosed balance after: 305,711 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 22:05 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 50,000 | $26.00 | $1,300,000.00 |
DisclosureSEC source: 0001209191-20-050028 · doc4.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Araxes Pharma LLC Disclosed balance after: 306,736 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 22:04 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionOption to purchase common stock · Derivative | 10,000 | $0.00 Strike: $15.47 | $0.00 |
DisclosureSEC source: 0001209191-20-050026 · doc4.xml · derivative · entry 3 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,898 Underlying: Common Stock · 10,000 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on January 22, 2019. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 22:04 UTC |
GRASSO MARCCFO, CBO
|
SaleCommon Stock | 10,000 | $26.00 | $260,000.00 |
DisclosureSEC source: 0001209191-20-050026 · doc4.xml · nonDerivative · entry 2 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 22:04 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionCommon Stock | 10,000 | $15.47 | $154,700.00 |
DisclosureSEC source: 0001209191-20-050026 · doc4.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:24 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 215 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-20-048438 · doc4.xml · derivative · entry 10 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,945 Underlying: Common Stock · 215 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F4 · derivative.exercise_date: This option vested in 48 equal monthly installments commencing on January 29, 2016. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:24 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 22,838 | $0.00 Strike: $6.15 | $0.00 |
DisclosureSEC source: 0001209191-20-048438 · doc4.xml · derivative · entry 9 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,977 Underlying: Common Stock · 22,838 shares Expires 2027-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F5 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on January 23, 2017. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:24 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 23,053 | $22.37 | $515,787.82 |
DisclosureSEC source: 0001209191-20-048438 · doc4.xml · nonDerivative · entry 5 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:24 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 215 | $4.80 | $1,032.00 |
DisclosureSEC source: 0001209191-20-048438 · doc4.xml · nonDerivative · entry 4 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:24 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 22,838 | $6.15 | $140,453.70 |
DisclosureSEC source: 0001209191-20-048438 · doc4.xml · nonDerivative · entry 3 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:22 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionOption to purchase common stock · Derivative | 10,000 | $0.00 Strike: $15.47 | $0.00 |
DisclosureSEC source: 0001209191-20-048436 · doc4.xml · derivative · entry 3 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,898 Underlying: Common Stock · 10,000 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on January 22, 2019. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:22 UTC |
GRASSO MARCCFO, CBO
|
SaleCommon Stock | 10,000 | $23.00 | $230,000.00 |
DisclosureSEC source: 0001209191-20-048436 · doc4.xml · nonDerivative · entry 2 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 22:22 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionCommon Stock | 10,000 | $15.47 | $154,700.00 |
DisclosureSEC source: 0001209191-20-048436 · doc4.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 20:25 UTC |
DALE STEPHENChief Medical Officer
|
GrantOption to purchase common stock · Derivative | 200,000 | $0.00 Strike: $21.98 | $0.00 |
DisclosureSEC source: 0001209191-20-048218 · doc4.xml · derivative · entry 1 DALE STEPHEN · CIK 0001821709 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2030-08-23 F1 · derivative.exercise_date: 1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 22:24 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 6,568 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-20-048438 · doc4.xml · derivative · entry 8 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,160 Underlying: Common Stock · 6,568 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F4 · derivative.exercise_date: This option vested in 48 equal monthly installments commencing on January 29, 2016. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 22:24 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 6,568 | $22.04 | $144,769.89 |
DisclosureSEC source: 0001209191-20-048438 · doc4.xml · nonDerivative · entry 2 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 22:24 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 6,568 | $4.80 | $31,526.40 |
DisclosureSEC source: 0001209191-20-048438 · doc4.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 11,913 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · derivative · entry 12 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,728 Underlying: Common Stock · 11,913 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F6 · derivative.exercise_date: This option vested in 48 equal monthly installments commencing on January 29, 2016. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 11,913 | $22.09 | $263,196.29 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 9 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 19, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 11,913 | $4.80 | $57,182.40 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 8 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 521 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · derivative · entry 11 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,641 Underlying: Common Stock · 521 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F6 · derivative.exercise_date: This option vested in 48 equal monthly installments commencing on January 29, 2016. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 521 | $22.00 | $11,462.00 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 7 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 521 | $4.80 | $2,500.80 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 6 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionOption to purchase common stock · Derivative | 12,901 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · derivative · entry 10 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,162 Underlying: Common Stock · 12,901 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F6 · derivative.exercise_date: This option vested in 48 equal monthly installments commencing on January 29, 2016. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 12,901 | $22.00 | $283,868.44 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 5 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 12,901 | $4.80 | $61,924.80 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 4 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 50,000 | $22.00 | $1,100,000.00 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 3 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Araxes Pharma LLC Disclosed balance after: 356,736 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
GiftCommon Stock | 26,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 2 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Red Fish Blue Fish Revocable Trust Disclosed balance after: 1,795,017 F1 · kind: This is a bona fide gift transaction exempt under Section 16(b). This transaction did not involve the sale of securities. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 22:38 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
GiftCommon Stock | 26,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047616 · doc4.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F1 · kind: This is a bona fide gift transaction exempt under Section 16(b). This transaction did not involve the sale of securities. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionOption to purchase common stock · Derivative | 7,102 | $0.00 Strike: $15.47 | $0.00 |
DisclosureSEC source: 0001209191-20-046161 · doc4.xml · derivative · entry 3 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,898 Underlying: Common Stock · 7,102 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F3 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on January 22, 2019. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
GRASSO MARCCFO, CBO
|
SaleCommon Stock | 10,000 | $20.00 | $200,000.00 |
DisclosureSEC source: 0001209191-20-046161 · doc4.xml · nonDerivative · entry 2 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
GRASSO MARCCFO, CBO
|
Exercise / conversionCommon Stock | 7,102 | $15.47 | $109,867.94 |
DisclosureSEC source: 0001209191-20-046161 · doc4.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · CFO, CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. F2 · balance_after: Includes 2,898 shares acquired on May 20, 2019 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.